Lawyer profile
Hannah England
Ropes & Gray
- Firm
- Ropes & Gray
- Practice
- IP transactions, life sciences, life sciences licensing
- Office
- Not stated
- Active in the record
- 2023 to 2025
Deal experience
Recent deals
11 announced deals in the record Ropes & Gray Advises Viridian Therapeutics in Japan Licensing Deal with Kissei Pharmaceutical for Thyroid Eye Disease Treatments 1 Aug 2025
Ropes & Gray Advises Gero in Chugai Pharmaceuticals Joint Research and License Agreement to Develop Novel Antibodies for Age-Related Diseases 21 Jul 2025
Ropes & Gray Advises Vir Biotechnology in Global License Agreement with Sanofi 13 Aug 2024
Ropes & Gray Advises Amylyx Pharmaceuticals in Acquisition of Phase 3-Ready Asset from Eiger BioPharmaceuticals 15 Jul 2024
Ropes & Gray Represents LianBio in Licensing Agreement with Janssen Pharmaceuticals in China and Other Asian Markets 29 Dec 2023
Ropes & Gray Advises Fauna Bio in $494 Million Strategic Collaboration with Lilly for AI Drug Discovery in Obesity with Data from Disease-Resistant Mammals 27 Dec 2023
Ropes & Gray Represents Accutar Biotechnology in Evommune AI Drug Discovery Collaboration 1 Dec 2023
Ropes & Gray Represents Acumen Pharmaceuticals in Halozyme Therapeutics Global Collaboration and License Agreement 8 Nov 2023
Ropes & Gray Advises LianBio in Agreement with Bristol Myers Squibb for Heart Drug Rights in Asia 27 Oct 2023
Ropes & Gray Represents Novo Nordisk in AI-Based Cardiometabolic Drug Discovery Collaboration with Valo Health Worth Up to $2.7 Billion 1 Oct 2023
Deal alerts PRO
Get an email when Hannah England is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile